EPIC-A: Phase II Trial of Cemiplimab Plus Standard-of-Care Chemotherapy Followed by Maintenance Cemiplimab in Locally Advanced or Metastatic Penile Carcinoma
Cisplatin-based combination chemotherapy is standard of care (SoC) for patients with locally advanced/metastatic penile cancer (la/mPC). We evaluated efficacy and safety of cemiplimab plus SoC chemotherapy as first-line treatment in these patients. In this phase II, single-arm, multicenter trial, patients...